e.g. Tata motors, Reliance MF, 500570

Corona Remedies Ltd. - Research Center

Group () BSE data
 
Back to Company Page
Results:
Statement:
More:

Profit loss account

(Rs crore)
Mar ' 25 Mar ' 24
Income
Operating income 1,196.42 1,014.47
Expenses
Material consumed 236.51 226.83
Manufacturing expenses 6.03 5.66
Personnel expenses 346.14 295.37
Selling expenses - -
Adminstrative expenses 367.75 331.89
Expenses capitalised - -
Cost of sales 956.44 859.74
Operating profit 239.98 154.74
Other recurring income 5.94 6.46
Adjusted PBDIT 245.91 161.19
Financial expenses 10.60 14.44
Depreciation 37.16 28.28
Other write offs - -
Adjusted PBT 198.15 118.48
Tax charges 49.10 27.98
Adjusted PAT 149.05 90.50
Non recurring items -0.87 -1.67
Other non cash adjustments - -
Reported net profit 148.18 88.82
Earnigs before appropriation 525.61 394.37
Equity dividend 22.63 16.94
Preference dividend - -
Dividend tax - -
Retained earnings 502.98 377.43
Close
Add Corona Remedies Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Corona Remedies Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback